Largest health care companies
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 1 | Eli Lilly & CoLLY | $1.29T | $1,369.96 | -3.39% | United States |
| 2 | Johnson & JohnsonJNJ | $656.3B | $272.63 | -1.33% | United States |
| 3 | AbbVieABBV | $510.3B | $288.70 | -2.08% | United States |
| 4 | Merck & Co.MRK | $362.2B | $146.94 | -2.28% | United States |
| 5 | UnitedHealth GroupUNH | $354.8B | $396.02 | -3.26% | United States |
| 6 | Philip Morris InternationalPM | $314.6B | $201.86 | -4.46% | United States |
| 7 | NovartisNVS | $309.0B | $161.93 | -1.85% | Switzerland |
| 8 | AstrazenecaAZN | $290.1B | $187.08 | -1.02% | United Kingdom |
| 9 | AmgenAMGN | $249.2B | $460.66 | -3.72% | United States |
| 10 | Gilead SciencesGILD | $207.8B | $167.53 | -3.98% | United States |
| 11 | Abbott LaboratoriesABT | $197.0B | $113.74 | -1.53% | United States |
| 12 | Novo Nordisk A SNVO | $178.7B | $40.36 | -4.33% | Denmark |
| 13 | PfizerPFE | $170.5B | $29.91 | -2.87% | United States |
| 14 | Intuitive SurgicalISRG | $162.7B | $469.31 | -2.65% | United States |
| 15 | Vertex PharmaceuticalsVRTX | $137.7B | $542.93 | -1.11% | United States |
| 16 | British American Tobacco p.l.c.BTI | $136.4B | $63.16 | +0.30% | United Kingdom |
| 17 | MedtronicMDT | $134.3B | $105.03 | +0.07% | United States |
| 18 | Altria GroupMO | $129.3B | $77.72 | -0.37% | United States |
| 19 | Bristol Myers SquibbBMY | $129.3B | $63.24 | -1.49% | United States |
| 20 | StrykerSYK | $127.5B | $334.96 | -1.38% | United States |
| 21 | McKessonMCK | $124.4B | $1,077.29 | +0.73% | United States |
| 22 | SanofiSNY | $114.3B | $46.87 | -1.27% | France |
| 23 | HCA HealthcareHCA | $106.3B | $508.66 | -0.40% | United States |
| 24 | GSKGSK | $101.9B | $50.38 | -1.50% | United Kingdom |
| 25 | 3MMMM | $97.0B | $187.66 | -3.24% | United States |
| 26 | ModernaMRNA | $96.5B | $241.79 | -6.42% | United States |
| 27 | Regeneron PharmaceuticalsREGN | $93.4B | $902.98 | -2.98% | United States |
| 28 | Elevance HealthELV | $93.3B | $431.64 | -0.59% | United States |
| 29 | Cigna GroupCI | $79.8B | $302.07 | -1.09% | United States |
| 30 | Takeda PharmaceuticalTAK | $67.1B | $21.25 | +0.88% | Japan |
| 31 | CencoraCOR | $64.9B | $340.33 | -3.86% | United States |
| 32 | Boston ScientificBSX | $64.7B | $44.61 | -2.65% | United States |
| 33 | Cardinal HealthCAH | $62.4B | $269.30 | +2.81% | United States |
| 34 | Becton Dickinson & CoBDX | $58.1B | $213.24 | +1.94% | United States |
| 35 | Edwards LifesciencesEW | $57.9B | $100.73 | +1.37% | United States |
| 36 | Argenx SeARGX | $55.8B | $898.86 | -3.49% | Netherlands |
| 37 | Idexx LaboratoriesIDXX | $52.9B | $671.42 | -3.88% | United States |
| 38 | NateraNTRA | $52.5B | $363.96 | -6.92% | United States |
| 39 | MedlineMDLN | $52.3B | $39.80 | -1.38% | United States |
| 40 | HumanaHUM | $49.3B | $410.34 | -1.70% | United States |
| 41 | Teva Pharmaceutical IndustriesTEVA | $48.7B | $41.77 | -0.20% | Israel |
| 42 | BeOne MedicinesONC | $44.0B | $387.35 | +2.53% | Cayman Islands |
| 43 | IqviaIQV | $43.6B | $264.76 | +0.37% | United States |
| 44 | Royalty PharmaRPRX | $38.9B | $67.75 | +0.28% | United States |
| 45 | Revolution MedicinesRVMD | $38.5B | $177.86 | -10.94% | United States |
| 46 | AlconALC | $38.3B | $76.69 | -0.80% | Switzerland |
| 47 | GE HealthCare TechnologiesGEHC | $37.9B | $83.84 | -2.30% | United States |
| 48 | CenteneCNC | $36.6B | $73.93 | -2.74% | United States |
| 49 | BiogenBIIB | $36.1B | $244.03 | -4.10% | United States |
| 50 | ZoetisZTS | $33.9B | $82.06 | -8.00% | United States |
| 51 | ResmedRMD | $33.7B | $239.87 | -0.27% | United States |
| 52 | Genmab A/SGMAB | $33.0B | $52.86 | -4.10% | Denmark |
| 53 | DexcomDXCM | $31.6B | $84.63 | -4.35% | United States |
| 54 | IlluminaILMN | $31.4B | $207.61 | -8.36% | United States |
| 55 | Koninklijke PhilipsPHG | $30.0B | $30.52 | -1.75% | Netherlands |
| 56 | LabcorpLH | $29.4B | $362.37 | -1.48% | United States |
| 57 | Quest DiagnosticsDGX | $28.0B | $254.20 | -0.58% | United States |
| 58 | West Pharmaceutical ServicesWST | $27.4B | $393.23 | -3.81% | United States |
| 59 | Roivant SciencesROIV | $26.5B | $36.70 | -4.00% | United Kingdom |
| 60 | STERISSTE | $24.8B | $254.55 | +2.68% | United States |
| 61 | United TherapeuticsUTHR | $24.1B | $566.79 | -6.85% | United States |
| 62 | IncyteINCY | $24.1B | $118.20 | -3.79% | United States |
| 63 | InsmedINSM | $23.9B | $108.76 | -1.13% | United States |
| 64 | Tenet HealthcareTHC | $22.8B | $286.81 | -1.86% | United States |
| 65 | ViatrisVTRS | $21.8B | $18.98 | -1.27% | United States |
| 66 | BioNTech SEBNTX | $21.6B | $86.01 | -5.18% | Germany |
| 67 | Alnylam PharmaceuticalsALNY | $21.0B | $156.95 | -2.57% | United States |
| 68 | Guardant HealthGH | $20.5B | $152.97 | -9.26% | United States |
| 69 | Zimmer BiometZBH | $20.3B | $107.46 | -2.44% | United States |
| 70 | MedpaceMEDP | $17.7B | $633.62 | -3.53% | United States |
| 71 | ExelixisEXEL | $16.8B | $68.70 | -5.57% | United States |
| 72 | Ascendis Pharma A/SASND | $16.7B | $253.39 | -1.76% | Denmark |
| 73 | Neurocrine BiosciencesNBIX | $16.2B | $160.29 | -3.47% | United States |
| 74 | UL SolutionsULS | $15.5B | $76.62 | -3.90% | United States |
| 75 | IconICLR | $15.4B | $201.60 | -0.74% | Ireland |
| 76 | Charles River Laboratories InternationalCRL | $15.0B | $314.07 | -3.75% | United States |
| 77 | SolventumSOLV | $14.8B | $87.09 | -2.53% | United States |
| 78 | Jazz PharmaceuticalsJAZZ | $14.6B | $227.19 | -3.18% | Ireland |
| 79 | BridgeBio PharmaBBIO | $14.5B | $74.31 | -4.60% | United States |
| 80 | Halozyme TherapeuticsHALO | $14.0B | $123.61 | -5.16% | United States |
| 81 | Encompass HealthEHC | $13.9B | $141.62 | +0.42% | United States |
| 82 | Smith & NephewSNN | $13.4B | $32.03 | -1.34% | United Kingdom |
| 83 | Baxter InternationalBAX | $13.3B | $25.62 | -3.34% | United States |
| 84 | Fresenius Medical CareFMS | $13.2B | $23.68 | +2.09% | Germany |
| 85 | BrightSpring Health ServicesBTSG | $13.1B | $65.84 | -5.67% | United States |
| 86 | GlaukosGKOS | $13.0B | $220.09 | -10.79% | United States |
| 87 | PenumbraPEN | $12.7B | $321.04 | -0.44% | United States |
| 88 | DavitaDVA | $12.2B | $194.63 | +1.02% | United States |
| 89 | Dr Reddys LaboratoriesRDY | $12.1B | $14.54 | -1.59% | India |
| 90 | Cooper CompaniesCOO | $12.1B | $63.59 | -1.29% | United States |
| 91 | Elanco Animal HealthELAN | $11.8B | $23.65 | -6.56% | United States |
| 92 | Universal Health ServicesUHS | $11.7B | $198.84 | +1.21% | United States |
| 93 | Summit TherapeuticsSMMT | $11.5B | $14.40 | -10.98% | United States |
| 94 | Bio-TechneTECH | $11.4B | $72.70 | -0.05% | United States |
| 95 | Molina HealthcareMOH | $11.3B | $216.77 | -4.26% | United States |
| 96 | Align TechnologyALGN | $11.2B | $159.46 | -3.30% | United States |
| 97 | Globus MedicalGMED | $10.9B | $81.44 | -6.50% | United States |
| 98 | Biomarin PharmaceuticalBMRN | $10.9B | $56.26 | -1.52% | United States |
| 99 | InsuletPODD | $10.9B | $156.50 | -5.16% | United States |
| 100 | Kymera TherapeuticsKYMR | $10.8B | $126.95 | -6.83% | United States |
Showing 1–100 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.